Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled study designed in 3 parts to
assess the safety, tolerability, and PK of single and multiple ascending doses of FPA008 in
adult healthy volunteers (Parts 1 and 2) and adult subjects with active RA (Part 3).